
Louise Wang Zhiying Humphrey
Supervisory Patent Examiner (ID: 4289, Phone: (571)272-5543 , Office: P/1657 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1657, 1648 |
| Total Applications | 627 |
| Issued Applications | 267 |
| Pending Applications | 54 |
| Abandoned Applications | 312 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7341584
[patent_doc_number] => 20040191272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response'
[patent_app_type] => new
[patent_app_number] => 10/833745
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 19897
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20040191272.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833745
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833745 | Methods and reagents for vaccination which generate a CD8 T cell immune response | Apr 27, 2004 | Abandoned |
Array
(
[id] => 820332
[patent_doc_number] => 07407661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-05
[patent_title] => 'Methods and reagents that generate a CD8 T cell immune response'
[patent_app_type] => utility
[patent_app_number] => 10/833744
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 41
[patent_no_of_words] => 19696
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/407/07407661.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833744
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833744 | Methods and reagents that generate a CD8 T cell immune response | Apr 27, 2004 | Issued |
Array
(
[id] => 7018797
[patent_doc_number] => 20050220816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Mutant viral nucleic acids and vaccine containing same'
[patent_app_type] => utility
[patent_app_number] => 10/814689
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21321
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220816.pdf
[firstpage_image] =>[orig_patent_app_number] => 10814689
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/814689 | Mutant viral nucleic acids and vaccine containing same | Mar 30, 2004 | Abandoned |
Array
(
[id] => 856942
[patent_doc_number] => 07375202
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-20
[patent_title] => 'Human virus causing severe acute respiratory syndrome (SARS) and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/808121
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 90
[patent_figures_cnt] => 14
[patent_no_of_words] => 23876
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/375/07375202.pdf
[firstpage_image] =>[orig_patent_app_number] => 10808121
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/808121 | Human virus causing severe acute respiratory syndrome (SARS) and uses thereof | Mar 23, 2004 | Issued |
Array
(
[id] => 288899
[patent_doc_number] => 07547512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-16
[patent_title] => 'High-throughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS)'
[patent_app_type] => utility
[patent_app_number] => 10/807807
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 106
[patent_figures_cnt] => 31
[patent_no_of_words] => 34004
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/547/07547512.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807807
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807807 | High-throughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) | Mar 23, 2004 | Issued |
Array
(
[id] => 5056884
[patent_doc_number] => 20070059806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection'
[patent_app_type] => utility
[patent_app_number] => 10/546034
[patent_app_country] => US
[patent_app_date] => 2004-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 27737
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546034 | Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection | Feb 23, 2004 | Issued |
Array
(
[id] => 7261480
[patent_doc_number] => 20040241183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Human lymphocyte vaccine adjuvant'
[patent_app_type] => new
[patent_app_number] => 10/783259
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6967
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241183.pdf
[firstpage_image] =>[orig_patent_app_number] => 10783259
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/783259 | Human lymphocyte medium adjuvant | Feb 19, 2004 | Issued |
Array
(
[id] => 7088532
[patent_doc_number] => 20050008644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Potentiation of the immune response'
[patent_app_type] => utility
[patent_app_number] => 10/778667
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3336
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20050008644.pdf
[firstpage_image] =>[orig_patent_app_number] => 10778667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/778667 | Potentiation of the immune response | Feb 12, 2004 | Abandoned |
Array
(
[id] => 7446978
[patent_doc_number] => 20040186066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Method of treatment with nelfinavir'
[patent_app_type] => new
[patent_app_number] => 10/776568
[patent_app_country] => US
[patent_app_date] => 2004-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11753
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186066.pdf
[firstpage_image] =>[orig_patent_app_number] => 10776568
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/776568 | Method of treatment with nelfinavir | Feb 9, 2004 | Abandoned |
Array
(
[id] => 5807663
[patent_doc_number] => 20060094017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Immunogens for hiv vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/544499
[patent_app_country] => US
[patent_app_date] => 2004-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7663
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094017.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544499
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544499 | Immunogens for hiv vaccine | Feb 9, 2004 | Abandoned |
Array
(
[id] => 922954
[patent_doc_number] => 07318926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-15
[patent_title] => 'Glycosylated specificity exchangers'
[patent_app_type] => utility
[patent_app_number] => 10/773628
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18745
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/318/07318926.pdf
[firstpage_image] =>[orig_patent_app_number] => 10773628
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/773628 | Glycosylated specificity exchangers | Feb 4, 2004 | Issued |
Array
(
[id] => 7677644
[patent_doc_number] => 20040152182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Viral particles released after infection by human cytomegalovirus, and their use as vaccine'
[patent_app_type] => new
[patent_app_number] => 10/770467
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8018
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152182.pdf
[firstpage_image] =>[orig_patent_app_number] => 10770467
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/770467 | Viral particles released after infection by human cytomegalovirus, and their use as vaccine | Feb 3, 2004 | Abandoned |
Array
(
[id] => 7316726
[patent_doc_number] => 20040223977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Fusion peptide HIV vaccines'
[patent_app_type] => new
[patent_app_number] => 10/769991
[patent_app_country] => US
[patent_app_date] => 2004-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7218
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20040223977.pdf
[firstpage_image] =>[orig_patent_app_number] => 10769991
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/769991 | Fusion peptide HIV vaccines | Feb 2, 2004 | Abandoned |
Array
(
[id] => 7423225
[patent_doc_number] => 20040265320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein'
[patent_app_type] => new
[patent_app_number] => 10/766528
[patent_app_country] => US
[patent_app_date] => 2004-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19222
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265320.pdf
[firstpage_image] =>[orig_patent_app_number] => 10766528
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/766528 | Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein | Jan 28, 2004 | Abandoned |
Array
(
[id] => 7599707
[patent_doc_number] => 07582740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-01
[patent_title] => 'Methods and kits for detecting SARS-associated coronavirus'
[patent_app_type] => utility
[patent_app_number] => 10/764075
[patent_app_country] => US
[patent_app_date] => 2004-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 6
[patent_no_of_words] => 8854
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/582/07582740.pdf
[firstpage_image] =>[orig_patent_app_number] => 10764075
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/764075 | Methods and kits for detecting SARS-associated coronavirus | Jan 22, 2004 | Issued |
Array
(
[id] => 7303207
[patent_doc_number] => 20040115184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Methods and compositions for modifying apolipoprotein b mrna editing'
[patent_app_type] => new
[patent_app_number] => 10/468987
[patent_app_country] => US
[patent_app_date] => 2004-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20992
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20040115184.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468987
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468987 | Methods and compositions for modifying apolipoprotein b mrna editing | Jan 8, 2004 | Abandoned |
Array
(
[id] => 7468023
[patent_doc_number] => 20040198960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae'
[patent_app_type] => new
[patent_app_number] => 10/483447
[patent_app_country] => US
[patent_app_date] => 2004-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10060
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198960.pdf
[firstpage_image] =>[orig_patent_app_number] => 10483447
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/483447 | Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae | Jan 6, 2004 | Abandoned |
Array
(
[id] => 6925799
[patent_doc_number] => 20050239054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Method and compositions for identifying anti-HIV therapeutic compounds'
[patent_app_type] => utility
[patent_app_number] => 10/740694
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 401863
[patent_no_of_claims] => 180
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10740694
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/740694 | Method and compositions for identifying anti-HIV therapeutic compounds | Dec 21, 2003 | Abandoned |
Array
(
[id] => 5776348
[patent_doc_number] => 20060104988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Vaccines against hiv-1 tat protein to generate neutralizing antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/539677
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17446
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20060104988.pdf
[firstpage_image] =>[orig_patent_app_number] => 10539677
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/539677 | Vaccines against hiv-1 tat protein to generate neutralizing antibodies | Dec 17, 2003 | Abandoned |
Array
(
[id] => 7318824
[patent_doc_number] => 20040224883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Compositions and methods for treating HIV infections'
[patent_app_type] => new
[patent_app_number] => 10/737288
[patent_app_country] => US
[patent_app_date] => 2003-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19631
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224883.pdf
[firstpage_image] =>[orig_patent_app_number] => 10737288
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/737288 | Compositions and methods for treating HIV infections | Dec 14, 2003 | Abandoned |